JP2022521446A5 - - Google Patents

Info

Publication number
JP2022521446A5
JP2022521446A5 JP2021572257A JP2021572257A JP2022521446A5 JP 2022521446 A5 JP2022521446 A5 JP 2022521446A5 JP 2021572257 A JP2021572257 A JP 2021572257A JP 2021572257 A JP2021572257 A JP 2021572257A JP 2022521446 A5 JP2022521446 A5 JP 2022521446A5
Authority
JP
Japan
Prior art keywords
intravenous formulation
formulation according
fenfluramine
patient
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021572257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521446A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/018359 external-priority patent/WO2020176276A1/en
Publication of JP2022521446A publication Critical patent/JP2022521446A/ja
Publication of JP2022521446A5 publication Critical patent/JP2022521446A5/ja
Pending legal-status Critical Current

Links

JP2021572257A 2019-02-25 2020-02-14 発作制御を改善するための製剤 Pending JP2022521446A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962810228P 2019-02-25 2019-02-25
US62/810,228 2019-02-25
PCT/US2020/018359 WO2020176276A1 (en) 2019-02-25 2020-02-14 A formulation for improving seizure control

Publications (2)

Publication Number Publication Date
JP2022521446A JP2022521446A (ja) 2022-04-07
JP2022521446A5 true JP2022521446A5 (cg-RX-API-DMAC10.html) 2022-12-07

Family

ID=72239800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572257A Pending JP2022521446A (ja) 2019-02-25 2020-02-14 発作制御を改善するための製剤

Country Status (4)

Country Link
US (1) US20220133652A1 (cg-RX-API-DMAC10.html)
EP (1) EP3930841A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022521446A (cg-RX-API-DMAC10.html)
WO (1) WO2020176276A1 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220044380A (ko) 2013-04-12 2022-04-07 이칸 스쿨 오브 메디슨 엣 마운트 시나이 외상후 스트레스 장애의 치료 방법
US9549909B2 (en) 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
DK3800177T3 (da) 2015-12-22 2025-03-31 Zogenix International Ltd Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
US10689324B2 (en) 2015-12-22 2020-06-23 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
RU2021106383A (ru) 2016-08-24 2021-04-05 Зодженикс Интернэшнл Лимитед Состав для ингибирования образования агонистов 5-ht2b и способы его применения
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
CA3097335A1 (en) 2018-05-11 2019-11-14 Zogenix International Limited Compositions and methods for treating seizure-induced sudden death
WO2020105005A1 (en) 2018-11-19 2020-05-28 Zogenix International Limited Methods of treating rett syndrome using fenfluramine
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
GB2597323A (en) * 2020-07-20 2022-01-26 Gw Res Ltd Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
US20240197704A1 (en) * 2021-04-09 2024-06-20 Johns Hopkins University Treatment methods and compositions comprising perampanel
EP4351727A4 (en) * 2021-05-28 2025-01-01 Icahn School of Medicine at Mount Sinai METHOD OF TREATMENT OF DRUG-RESISTANT EPILEPSY
US12667723B2 (en) 2022-04-08 2026-06-30 Patrick M. Nemechek Systems and methods for treating autism spectrum disorder, developmental disorders and other medical conditions
CN117530933B (zh) * 2024-01-10 2024-05-10 江苏长泰药业股份有限公司 一种吡仑帕奈长效缓释微球、制备方法及缓释注射剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0410266D0 (en) * 2004-05-07 2004-06-09 Ketocytonyx Inc Treatment of apoptosis
EP2355818A4 (en) * 2008-10-10 2012-04-11 Us Of America As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army Inst Of Res METHOD AND COMPOSITIONS FOR TREATING THE STATUS EPILEPTICUS AND STATUS EPILEPTICUS CAUSING ATTACHMENTS
US9549909B2 (en) * 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
JP2018504420A (ja) * 2015-02-06 2018-02-15 マリナス ファーマシューティカルズ インコーポレイテッド 静注用ガナキソロン製剤ならびにてんかん重積状態および他の発作性障害の治療におけるその使用
KR102615486B1 (ko) * 2015-08-24 2023-12-19 조게닉스 인터내셔널 리미티드 펜플루라민을 사용하여 레녹스-가스토 증후군을 치료하는 방법

Similar Documents

Publication Publication Date Title
JP2022103194A (ja) S1p受容体アゴニストの投与レジメン
Bryson et al. Individualized anesthetic management for patients undergoing electroconvulsive therapy: a review of current practice
US9913833B2 (en) Methods of treating developmental disorders using pipradrol
EP3930841A1 (en) A formulation for improving seizure control
JP2006117689A (ja) 置換フェネチルアミン類を用いた医薬組成物
TW202002971A (zh) 治療疼痛的方法
TW200918077A (en) Compositions and methods employing NMDA antagonists for achieving an anesthetic-sparing effect
WO2008116890A2 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
US20100227916A1 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
TWI304735B (en) Carbamate compounds for use in the treatment of pain
EA013591B1 (ru) Применение пептидных соединений для профилактики, облегчения и лечения головной боли и болезненных состояний, связанных с или вызванных распространяющейся кортикальной депрессией (csd)
JP2021152060A (ja) アカンプロセートおよびd−サイクロセリンを使用する組み合わせ療法
JP2023526517A (ja) 運動失調症を治療するためのアセチルロイシンと4-アミノピリジン又はアセタゾラミドとの組合せ
WO2002064213A1 (es) Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la dependencia de cocaina
CN101636391A (zh) 神经病理性疼痛的新型预防剂和/或治疗剂
RU2120283C1 (ru) Способ лечения эпилепсии
US20230000796A1 (en) Intranasal administration of ketamine to cluster headache patients
RU2227028C1 (ru) Способ лечения невралгии тройничного нерва
US11364218B2 (en) Method of treating or preventing mood disorders, mental disorders, and/or chronic fatigue syndrome
JP2024502466A5 (cg-RX-API-DMAC10.html)
Adkoli Symptomatic hyponatremia in patients on oxcarbazepine therapy for the treatment of neuropathic pain: two case reports
JP2021509671A5 (cg-RX-API-DMAC10.html)
Bacon et al. NONVERBAL AUTISTIC 30-YEAR-OLD FOR FULL MOUTH DENTAL REHABILITATION WITH MALIGNANT HYPERTHERMIA
RU2641163C1 (ru) Способ лечения устойчивых пароксизмальных состояний и генерализованных миоклоний у пациентов с последствиями тяжелого поражения головного мозга
JP2017088584A (ja) 医薬組成物